ストックスクリーナーアプリを入手
5.33
1.14%
0.06
Autonomix Medical Inc (AMIX) 最新ニュース
Autonomix (AMIX) Momentum: Moves 10.83% Down to $5.27 in the Latest Reading; Trading Range: $5.01 and $5.53 Define the Nearby Reference Levels in the Current UpdateVolume Gap - Vinanet
Autonomix Medical enters $2.6 million warrant inducement agreement - scanx.trade
Autonomix (AMIX) Earnings Reading: Profit Per Share Surpasses Its Benchmark at the Close; Share Response: The Stock Records a 4.21% Decrease in Latest TradingEPS Surprise History - Vinanet
Autonomix (AMIX) Quarterly Results: EPS Prints Above Forecast; After Earnings: Shares Fall 3.40% in the Current UpdateEarnings Decline Risk - Vinanet
Autonomix (AMIX) Quarterly Update: EPS Lands Above Forecast in the Current Update; Price Reaction: Shares Finish 5.86% Down in the Latest SessionFinancial Health Score - dars.gov.et
Autonomix Medical completes pre-clinical study for FDA submission By Investing.com - Investing.com Nigeria
Autonomix Medical (AMIX) Holds at $6.85 as Narrow Trading Range Defines Near-Term OutlookETF Creation Redemption - Vinanet
Price to sales forward of Autonomix Medical, Inc. – NASDAQ:AMIX - TradingView
Autonomix Medical, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2026 - marketscreener.com
Autonomix Medical Q1 Results: EPS of $(5.02) beats estimate - scanx.trade
Autonomix Medical (AMIX) flags going-concern risk and $25–$30M funding need - Stock Titan
Autonomix Medical, Inc. (AMIX) Stock Price, News, Quote & History - Yahoo! Finance Canada
Autonomix Medical Stock Short Interest Rises to 50.21% - Moomoo
Autonomix Medical completes pre-clinical study for FDA submission - Investing.com
Autonomix Medical Completes Good Laboratory Practice (GLP) Preclinical Study, Marking Key Step Toward FDA Submission - The Manila Times
Autonomix Medical Completes GLP Pre-Clinical Study, Advancing FDA Submission - Quiver Quantitative
Autonomix CMO Robert Schwartz receives lifetime award - Investing.com
Autonomix CMO Robert Schwartz receives cardiovascular award By Investing.com - Investing.com Australia
Autonomix CMO Robert Schwartz receives lifetime award By Investing.com - Investing.com South Africa
Autonomix CMO Robert Schwartz receives cardiovascular award - Investing.com
Autonomix Medical Congratulates Co-Founder & Chief Medical Officer Dr. Robert Schwartz on Receiving Prestigious 2026 Cardiovascular Tech Forum Lifetime Achievement Award - The Manila Times
Autonomix Medical Congratulates Chief Medical Officer Robert Schwartz on 2026 CTF Lifetime Achievement Award - Quiver Quantitative
Cardiovascular Innovator With 500+ Papers, 200+ Patents to Receive Award - Stock Titan
Why Autonomix Medical (AMIX) Stock Is Down Today - Quiver Quantitative
AMIX Stock Rockets On Resale News As Dilution Risks Build - StocksToTrade
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
AMIX Stock Rockets As Cash Deals Collide With Dilution Fears - StocksToTrade
Autonomix Medical Soars 434% as Patent Filings Indicate 2025 GrantThe Wall Street Journal - TechStock²
Autonomix Medical, Inc. SEC Filing (Aug 5, 2026) - Stock Titan
SpaceX, AMD, Nvidia, Astera Labs and Autonomix Medical: Why These 5 Stocks Are on Investors' Radars Today - Sahm
SPCX, AMD, NVDA, ALAB, AMIX: 5 Trending Stocks TodayAdvanced Micro Devices (NASDAQ:AMD) - Benzinga
Autonomix Medical receives patent for nerve-targeting cancer tech By Investing.com - Investing.com UK
$Autonomix Medical (AMIX.US)$ On at 17.31 sold shares at esch level above entry, holding runners - Moomoo
Autonomix Stock Skyrockets After Obtaining Key Cancer Tech Patent - benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Why Autonomix Medical Stock Has More Than Doubled Today - AskTraders
Autonomix Medical Receives U.S. Patent for Precision Neuromodulation Platform Expansion - Yahoo Finance
Why is Autonomix Medical stock surging today? By Investing.com - Investing.com India
Autonomix Medical receives patent for nerve-targeting cancer tech - Investing.com
AMIX Stock Whipsaws As Patent Wins And Data Fuel Speculation - timothysykes.com
Autonomix Medical Expands Precision Neuromodulation Platform with Broad New U.S. Patent Supporting Nerve Sensing, Mapping and Targeted Therapy - marketscreener.com
Autonomix patent covers mapping nerves tied to tumors and cancer pain - Stock Titan
Autonomix Medical secures U.S. patent for precision nerve sensing and cancer pain therapy - scanx.trade
$Autonomix Medical (AMIX.US)$ Its literally saying buy me here - Moomoo
$Autonomix Medical (AMIX.US)$ thats 21 PT hit next one at 37 - Moomoo
Autonomix Medical (AMIX) surges as traders react to recent renal-study data and fresh patent updates - Quiver Quantitative
Autonomix Medical, Inc. (NASDAQ:AMIX) rises as cash-per-share differential aligns with warrant overhang - TechStock²
Autonomix Medical stock halts, surges 116% on preclinical data - scanx.trade
Autonomix Medical Inc (AMIX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Autonomix Medical (AMIX) Stock Rallies Over 54% After Hours: Here's Why - Sahm
Autonomix Medical Inc (AMIX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Autonomix Medical Inc (AMIX) Institutional Confidence - TradingKey
Autonomix Medical Inc (AMIX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Autonomix Medical Inc (AMIX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
AMIX|Autonomix Medical Inc|Price:2.920|Chg%:-0.580 - TradingKey
Autonomix Medical Inc (AMIX) Balance Sheet - TradingKey
AMIX Q2 2026 Earnings: EPS Surprises to the Upside Amid Ongoing R&D FocusEarnings Sentiment Score - Vinanet
AMIX|Autonomix Medical Inc|Price:2.755|Chg%:-0.165 - TradingKey
1.36%
0.31%
大文字化:
|
ボリューム (24 時間):